Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on Apomorphine and Psilocybin for Recovery in Coma Patients with Acute Brain Injury
DenmarkLong-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis
BulgariaEvaluation of Bevacizumab in Patients with Brain Radionecrosis After Radiation Treatment for Brain Metastases
FranceStudy on the Safety and Effectiveness of TZ-161 for Adults with Early Acute Spinal Cord Injury
PortugalStudy on the Use of Thiamine and Biotin for Patients with Huntington's Disease
SpainStudy on Modafinil for Improving Cognitive Deficits in Multiple Sclerosis Patients
PortugalStudy on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
BulgariaStudy on Dexmedetomidine, Midazolam, and Lorazepam for Treating Acute Agitation in Emergency Psychiatry Patients
DenmarkStudy of flecainide alone or with beta-blockers or calcium channel blockers and quinidine for treating ventricular arrhythmias in patients with Andersen-Tawil syndrome and MEPPC
The NetherlandsStudy on Efavirenz for Patients with Early Alzheimer's Disease
The NetherlandsStudy on Donepezil for Mild Cognitive Impairment in Parkinson's Disease Patients
SpainStudy on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis
BelgiumThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
